Slaven Stekovic
President chez Multiomic Health Ltd.
Profil
Slaven Stekovic is currently a Venture Partner at Selvedge Innovation LLP and the President & Chief Operating Officer at Multiomic Health Ltd.
Previously, he worked as the Chief Scientific Officer at Longevity Labs, Inc. from 2016 to 2018.
He holds an MBA from the University of Cambridge, a doctorate and a graduate degree from the University of Graz.
Postes actifs de Slaven Stekovic
| Sociétés | Poste | Début |
|---|---|---|
Multiomic Health Ltd.
 Multiomic Health Ltd. BiotechnologyHealth Technology Multiomic Health Ltd. is a British AI-enabled drug discovery company that focuses on chronic multi-factorial diseases, particularly metabolic syndrome-related conditions. Multiomic Health is based in London, UK. The company partners with research institutions, healthcare providers, and healthtech companies to source de-identified patient data and samples. Multiomic's MOHSAIC® platform combines integrated multi-omics analysis and computational systems biology modeling with targeted wet laboratory experiments to originate novel precision therapeutic concepts. The company subsequently partners with established biopharma companies to take its therapeutic concepts into clinical trial programs and market the ensuing medicines. The company was founded in 2021 by Robert Vee-Lin Thong and Alasdair Thong, and Robert Vee-Lin Thong has been the CEO since 2021. | President | 01/01/2021 |
Selvedge Innovation LLP
 Selvedge Innovation LLP Investment ManagersFinance Selvedge Innovation LLP (Selvedge Venture) is a venture capital firm founded in 2019 by Alasdair Thong and Robert Thong. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01/12/2021 |
Anciens postes connus de Slaven Stekovic
| Sociétés | Poste | Fin |
|---|---|---|
Longevity Labs, Inc.
 Longevity Labs, Inc. Internet RetailRetail Trade Longevity Labs, Inc. is an American company that specializes in developing natural spermidine products to support cellular rejuvenation and renewal. The private company's flagship product, SpermidineLife®, is a dietary supplement that activates the cell's autophagy process, allowing cells to regenerate and operate at their highest efficiency. Longevity Labs is headquartered in the United States and has production facilities in multiple locations. The CEO of the company is Daniel Dietz. | Corporate Officer/Principal | 01/01/2018 |
Formation de Slaven Stekovic
| University of Cambridge | Masters Business Admin |
| University of Graz | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Longevity Labs, Inc.
Longevity Labs, Inc. Internet RetailRetail Trade Longevity Labs, Inc. is an American company that specializes in developing natural spermidine products to support cellular rejuvenation and renewal. The private company's flagship product, SpermidineLife®, is a dietary supplement that activates the cell's autophagy process, allowing cells to regenerate and operate at their highest efficiency. Longevity Labs is headquartered in the United States and has production facilities in multiple locations. The CEO of the company is Daniel Dietz. | Retail Trade |
Selvedge Innovation LLP
Selvedge Innovation LLP Investment ManagersFinance Selvedge Innovation LLP (Selvedge Venture) is a venture capital firm founded in 2019 by Alasdair Thong and Robert Thong. The firm is headquartered in London, United Kingdom. | Finance |
Multiomic Health Ltd.
Multiomic Health Ltd. BiotechnologyHealth Technology Multiomic Health Ltd. is a British AI-enabled drug discovery company that focuses on chronic multi-factorial diseases, particularly metabolic syndrome-related conditions. Multiomic Health is based in London, UK. The company partners with research institutions, healthcare providers, and healthtech companies to source de-identified patient data and samples. Multiomic's MOHSAIC® platform combines integrated multi-omics analysis and computational systems biology modeling with targeted wet laboratory experiments to originate novel precision therapeutic concepts. The company subsequently partners with established biopharma companies to take its therapeutic concepts into clinical trial programs and market the ensuing medicines. The company was founded in 2021 by Robert Vee-Lin Thong and Alasdair Thong, and Robert Vee-Lin Thong has been the CEO since 2021. | Health Technology |
